Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel ERK inhibitors designed

April 18, 2012

Highly potent and selective EZH2 inhibitors discovered by GSK

April 18, 2012

Preclinical results demonstrate significant early antitumor efficacy of new immunotherapy

April 18, 2012

Sanofi presents novel oncolytic drug candidate

April 18, 2012

BioAlliance plans phase II Clonidine Lauriad study expansion

April 18, 2012

New Exp1 inhibitors show promise in a number of in vitro and in vivo cancer studies

April 18, 2012

Daiichi Sankyo launches Ranmark in Japan

April 17, 2012

Merck & Co. gains worldwide rights to anticancer conjugate

April 17, 2012

Regeneron Pharmaceuticals generates new anticancer antibody

April 17, 2012

Two new promising oncology programs presented

April 17, 2012

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...